Search results
Results from the WOW.Com Content Network
[13] [14] In 2016, the research and development spending by pharmaceutical companies in the US was estimated to be around $59 billion (equivalent to $73.5 billion in 2023 [108]). [111] In 2006, the US accounted for three quarters of the world's biotechnology revenues and 82% of world R&D spending in biotechnology.